Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia

Patients with high risk myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) are commonly older with multiple co-morbidities, rendering them unsuitable for intensive induction chemotherapy or transplantation. We report preliminary cellular immune profiling of four cases receiving seq...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Leuk Res Rep
Hlavní autoři: Jain, Prachi, Klotz, Jeffrey, Dunavin, Neil, Lu, Kit, Koklanaris, Eleftheria, Draper, Debbie, Superata, Jeanine, Chinian, Fariba, Yu, Quan, Keyvanfar, Keyvan, Wong, Susan, Muranski, Pawel, Barrett, A. John, Ito, Sawa, Battiwalla, Minoo
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5402630/
https://ncbi.nlm.nih.gov/pubmed/28462085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2017.04.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky